Organon Beats On Q1, Women's Health Leads the Charge - Organon (NYSE:OGN)

Organon reported 5% increase in Q1 2024 revenue of $1.622 billion, beating consensus. EPS of $1.22 and dividend of $0.28 declared.

Related Keywords

China ,Canada ,Brazil , ,Spdr Sp Pharmaceuticals ,Women Health ,Invesco Sp Smallcap Health Care ,Organon Co ,Volume Based Procurement ,